生物标志物 生物标志物
Karin L Meeker1, Gordon An2, Aristeidis Sotiras3
1Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, TX, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
阿尔茨海默氏病 (AD) 脑缩表现出不同的亚型,中位时间节省与更高的病理和认知衰退有关. 这些空间缩模式可以在不同的人群中推广.
科学领域:
- 神经成像是一种神经成像.
- 阿尔茨海默氏症疾病研究研究
- 大脑缩 亚型化 脑缩
背景情况:
- 阿尔茨海默病 (AD) 的生物异质性与不同的临床结果和治疗反应有关.
- 空间缩模式一直被确定,但它们在不同人群中的概括性仍然不清楚.
- 这项研究旨在在一个大型的代表性样本中表征空间缩亚型及其相关配置文件.
研究的目的:
- 在多元化,基于社区的队列中识别和描述阿尔茨海默病 (AD) 的空间缩亚型.
- 调查这些已识别的亚型的社会人口统计学,并发症,认知和病理相关性.
- 评估空间缩亚型在民族种族群体中的通用性.
主要方法:
- 利用了来自健康和衰老大脑研究 - 健康差异 (HABS-HD) 队列的结构性MRI数据,包括多样化的参与者.
- 应用了子类型和阶段推断 (SuStaIn) 算法来导出空间缩子类型.
- 在已识别的亚型中比较社会人口统计,并发症,认知和生物标志物 (粉样蛋白/粉样蛋白,白质超强度) 数据.
主要成果:
- 除了对照组外,还确定了三个主要的缩亚型:中位时间 (MTL) 主导,MTL节约和扩散缩.
- 缩的个体,特别是MTL节约亚型的人,表现出更大的阿尔茨海默氏症病理 (粉样,),较差的认知能力,以及更高的认知障碍率.
- 缩亚型在西班牙裔,黑人和白人参与者之间分布相似,这表明可概括性.
结论:
- 阿尔茨海默病 (AD) 中的空间缩亚型在不同人群中是可概括的,并且与不同的病理和认知特征相关.
- 这些发现表明,临床结果和治疗反应可能因缩亚型而异.
- 这些见解可以为临床试验的设计提供信息,并为AD提前准确医学方法.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516